1. Acknowledgement to Referees

   Acknowledgement to Referees 20 November 2015 Pages: 375 - 377

2. Meta-Analyses of Statin Therapy for Primary Prevention Do Not Answer Key Questions: An Empirical Appraisal of 5 Years of Statin Meta-Analyses

   • Chetan Huded
   • Vinay Prasad

   Current Opinion 04 July 2015 Pages: 379 - 386

   

3. Most Heart Failure Patients Die from Pump Failure: Implications for Therapy

   • Antonio Carlos Pereira-Barretto
   • Fernando Bacal
   • Denilson Campos de Albuquerque

   Current Opinion 04 August 2015 Pages: 387 - 393

   

4. Rivaroxaban in the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation: Clinical Implications of the ROCKET AF Trial and Its Subanalyses

   • Ryan J. Spencer
   • John V. Amerena

   Review Article 11 June 2015 Pages: 395 - 401

5. Hypercholesterolemia and Hypertension: Two Sides of the Same Coin

   • Branislava Ivanovic
   • Marijana Tadic

   Review Article 11 June 2015 Pages: 403 - 414

6. Cost Effectiveness of Antiplatelet and Antithrombotic Therapy in the Setting of Acute Coronary Syndrome: Current Perspective and Literature Review

   • Zaher Fanari
   • Sandra Weiss
   • William S. Weintraub

   Review Article 12 June 2015 Pages: 415 - 427

   

7. Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis

   • Xiao-Chen Wang
   • Dong-Min Zhu
   • Yu-Xuan Shan

   Systematic Review 28 June 2015 Pages: 429 - 437

   

8. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry

   • Pil Sang Song
   • Sang-Hoon Seol
   • Other Korean Working Group in Myocardial Infarction (KorMI) Registry Investigators

   Original Research Article 08 July 2015 Pages: 439 - 449

   

9. Erratum to: Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs)

   • Sebastian Werth
   • Tomás Breslin
   • Jan Beyer-Westendorf

   Erratum 17 November 2015 Pages: 451 - 452